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Activated c-Abl is degraded by the ubiquitin-dependent
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Asier Echarri and Ann Marie Pendergast
C-Abl is a nonreceptor tyrosine kinase that is tightly and tyrosine-phosphorylated c-Abl SH3 [7, 8] into 293T
cells andmonitored their stability by pulse-chase analysis.regulated in the cell. Genetic data derived from
studies in flies and mice strongly support a role for The steady-state levels of the overexpressed wild-type
and SH3 forms of c-Abl were increased 10-fold overAbl kinases in the regulation of the cytoskeleton
(reviewed in [1, 2]). C-Abl can be activated by several endogenous c-Abl. Under these conditions, the c-Abl
wild-type protein is not activated by overexpression [9].stimuli, including oxidative stress [3], DNA damage
[4], integrin engagement [5], growth factors, and Src Activated c-Abl SH3 is more unstable (mean half-life
of 7  2.3 hr) than wild-type c-Abl (half-life of 18 family kinases [6]. Structural alterations elicit
constitutive activation of the c-Abl tyrosine kinase, 4.8 hr) (Figure 1a). The c-Abl LX mutant transforms
fibroblasts, but does not transform primary bone marrowleading to oncogenic transformation. While the
mechanisms that activate c-Abl are beginning to be cells, and shows low to undetectable levels of autophos-
phorylation on tyrosine [10]. If tyrosine phosphorylationelucidated, little is known regarding the
mechanisms that downregulate activated c-Abl. is required for decreased protein stability, then the stabil-
ity of c-Abl LX should be similar to that of c-Abl. AsHere, we show for the first time that activated c-Abl
is downregulated by the ubiquitin-dependent shown in Figure 1a, the stability of c-Abl LX is similar
to c-Abl, with a half-life of 13 hr, and correlates with thedegradation pathway. Activated forms of c-Abl are
more unstable than wild-type and kinase-inactive phosphotyrosine status of the proteins [10].
forms. Moreover, inhibition of the 26S proteasome
leads to increased c-Abl levels in vitro and in cells, An in vitro assay was employed to monitor the stability
and activated c-Abl proteins are ubiquitinated in of wild-type c-Abl and activated c-Abl mutants [11]. As
vivo. Significantly, inhibition of the 26S proteasome shown in Figure 1b, c-Abl SH3 is more unstable (half-
in fibroblasts increases the levels of tyrosine- life 2.5  0.1 hr) than c-Abl wild-type (half-life 5.2  1.1
phosphorylated, endogenous c-Abl. Our data hr). To rule out the possibility that a complete deletion
suggest a novel mechanism for irreversible of the SH3 domain may affect the proper folding of c-Abl
downregulation of activated c-Abl, which is critical SH3 and produce an unstable protein, we tested c-Abl
to prevent the deleterious consequences of c-Abl point mutants that are constitutively activated. The point
hyperactivation in mitogenic and cytoskeletal mutation of proline 131 to leucine (P131L) in the Abl
pathways. SH3 domain disrupts the interaction between proline-rich
targets and the SH3 domain, leading to activation of c-Abl
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K290R protein (half-life of 6.3  1.2 hr) is significantly
more stable than activated c-Abl proteins and slightly
more stable than wild-type c-Abl (Figure 1b). Thus, thereResults and discussion
is an excellent inverse correlation between the activationActivated and tyrosine-phosphorylated forms of c-Abl
state and the stability of different c-Abl forms, in whichare more unstable than inactive c-Abl proteins
the active proteins that are tyrosine phosphorylated areTo test whether activated c-Abl is downregulated through
more unstable than the inactive ones.decreased protein stability, we compared the stability of
constitutively activated forms of c-Abl to that of inactive
c-Abl. We transfected c-Abl or constitutively activated To examine whether activation of c-Abl by mechanisms
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Figure 1
Activated and tyrosine-phosphorylated forms of the c-Abl kinase have degradation reaction mix. Samples were taken at the indicated times
decreased protein stability. (a) In vivo pulse-chase analysis of c-Abl, (left panel) and quantified as in (a) (right panel). The data are
c-Abl LX, and activated c-Abl SH3 is shown. 293T cells were representative of three independent experiments. (c) The stability of
transfected with plasmids encoding c-Abl, c-Abl LX, or c-Abl SH3, in vitro-translated wild-type c-Abl and kinase-inactive c-Abl K290R
and after 48 hr, the cells were pulse-chased and the c-Abl proteins was determined as in (b) in the presence of in vitro-synthesized
were immunoprecipitated (left panel) and quantified by luciferase control protein () or activated Src 527F (). Quantified
phosphoimager (right panel). The stability (% c-Abl remaining) is data are contained in the right panel. (d) The stability of endogenous
indicated as the mean  standard deviation (S.D.) of three c-Abl was analyzed in Cos-7 cells in the absence () or presence
independent experiments. (b) The stability of in vitro-translated wild- of transfected Fyn 528F (). The stability of endogenous c-Abl was
type c-Abl, kinase-inactive c-Abl K290R, and constitutively activated determined by pulse-chase analysis as in (a). Quantified data are
c-Abl SH3 and c-Abl K241E/P242G proteins was examined. The contained in the right panel. The data are representative of two
radiolabeled proteins were incubated at 37C in a protein independent experiments.
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Figure 2
Phosphorylation on tyrosines 245 and 412 affects the stability of wild- independent experiments (right panel). Cell lysates were
type c-Abl, but not activated c-Abl P131L. (a) In vivo pulse-chase immunoblotted (IB) for c-Abl (middle panel) and anti-
analysis of c-Abl and c-Abl Y245F/Y412F is shown. 293T cells were phosphotyrosine antibodies (lower panel). (b) In vivo pulse-chase
transfected with the indicated plasmids, and proteins were analyzed analysis of c-Abl P131L and c-Abl P131L/Y245F/Y412F is shown.
as in Figure 1a (left panel). Protein stability (% c-Abl remaining) is Cell lysates were analyzed as in (a).
indicated as the mean  standard deviation (S.D.) of three
other than mutations induces its downregulation, we ex- To further examine the correlation between protein sta-
bility and activation of c-Abl kinases by tyrosine phosphor-amined the effect of activated Src kinases on the stability
of c-Abl. We have previously shown that Src family ki- ylation, we compared the stability of c-Abl and c-Abl
Y245F/Y412F. Tyrosines 245 and 412 are the two majornases, including Src and Fyn, can tyrosine phosphorylate
and activate c-Abl [6]. As shown in Figure 1c, activated phosphorylated tyrosines on activated c-Abl in vitro, and
phosphorylation at these two sites was shown to enhanceSrc 527F induces rapid downregulation of in vitro-trans-
lated c-Abl wild-type and c-Abl K290R, with a 40% and c-Abl activity in vitro by 20-fold [14]. Expression of the
c-Abl proteins was under the control of the CMV pro-50% reduction in the corresponding half-lives, respec-
tively. We also examined the stability of endogenous moter, which results in high-level overexpression. Under
this condition, c-Abl, but not c-Abl Y245F/Y412F, is tyro-c-Abl in vivo in Cos-7 cells in the absence or presence of
activated Fyn 528F (Figure 1d). Endogenous c-Abl is sine phosphorylated and activated [9, 14]. The overex-
pressed and activated c-Abl is more unstable (half-life ofmore unstable in the presence of activated Fyn 528F
(half-life of 4.5 hr). The decrease in the half-life of endog- 7.2  1.9 hr) than the non-tyrosine-phosphorylated c-Abl
Y245F/Y412F (half-life of 14.2  0.3 hr) (Figure 2a). Theenous c-Abl in the presence of Fyn 528F is likely to be
an underestimate since the transfection efficiency for Fyn half-lives of c-Abl Y245F and c-Abl Y412F are 11.3 and
11.7 hr, respectively (data not shown). Thus, activation528F is about 40%–60%. Moreover, only the cytosolic,
but not the nuclear, pool of c-Abl is activated by Fyn of c-Abl by phosphorylation on tyrosines 245 and 412
leads to its destabilization. However, in the context of528F, whereas the pulse-chase assay shown measures the
half-life for the total pool of c-Abl. Taken together, these the structurally altered c-Abl P131Lmutant, tyrosines 245
and 412 do not play a major role on protein stability. Asresults show that activation of c-Abl by mutations that
induce tyrosine phosphorylation or by tyrosine phosphory- shown in Figure 2b, c-Abl P131L, c-Abl P131L/Y245F/
Y412F, and c-Abl P131L/Y412F (data not shown) showlation by Src family kinases results in decreased protein
stability. similar stability (half-lives of 5.6  0.8, 6.3  0.1, and 5
Figure 3
Inhibition of the ubiquitin-dependent 26S proteasome machinery leads (20 M) for 6 hr in the presence of cycloheximide (100 g/ml) and
to the accumulation of c-Abl. (a) The stability of in vitro-translated were lysed in RIPA buffer. c-Abl was immunoprecipitated (IP) and detected
c-Abl and c-Abl P131L was examined at various times after transfer by immunoblotting with anti-phosphotyrosine antibodies (upper panel,
into the protein degradation mix (left panel). Where indicated, ATP -pTyr). Total lysate was immunoblotted with c-Abl monoclonal
was substituted by the nonhydrolyzable ATPS (2 mM). The antibody (middle panel) and Erk p42 (lower panel). This experiment is
radiolabeled proteins were quantified as in Figure 1b (right panel). representative of three independent experiments. (e) NIH 3T3 cells were
Data were calculated from two independent experiments. (b) The pretreated with lactacystin (10 M) for 4 hr and 15 min, followed by
stability of activated c-Abl SH3 produced in vitro was analyzed as PDGF [6] and pervanadate treatment (to inhibit the PEST-type tyrosine
in Figure 1b in the absence (DMSO) or presence of MG132 (200 phosphatase activity that dephosphorylates c-Abl [21]). Immunopurified
M). The data are representative of two independent experiments. c-Abl was detected by immunoblotting with anti-phosphotyrosine
(c) The stability of c-Abl SH3 was analyzed in vivo as in Figure 1a. antibodies (upper panel). The film in the upper left panel was exposed
293T cells were incubated with radiolabeled amino acids in the 20 times longer than the film in the upper right panel. Total lysates
absence (DMSO) or presence of the MG132 (30 M). The data were immunoblotted with c-Abl monoclonal antibody (middle panel) and
are representative of three independent experiments. (d) 10T1/2 Actin or Erk p42 (lower panels). This experiment is representative of
fibroblasts expressing v-Src were treated with DMSO or MG132 three independent experiments.
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Figure 4
Activated forms of c-Abl are ubiquitinated. (a) 293T cells were c-Abl monoclonal antibody. (b) Duplicate cells were lysed in RIPA
cotransfected in duplicate with his-tagged ubiquitin (His-Ub) and buffer, and the Abl proteins were immunoprecipitated from the
empty vector or vector encoding for the indicated proteins. After 48 hr, lysates. The immunopurified complexes were blotted with anti-
one set of cells was lysed, and the ubiquitin complexes were purified. phosphotyrosine monoclonal antibody. (c,d) Cell lysates were
The purified fraction was subjected to immunoblotting with immunoblotted for (c) c-Abl and (d) Fyn 528F proteins.
hr, respectively) independent of tyrosine phosphorylation. To test whether the activated c-Abl proteins are downreg-
ulated by the 26S proteasome, we measured the half-lifeThese results demonstrate that tyrosines 245 and 412 are
important for activating and regulating the stability of c-Abl of activated c-Abl SH3 produced in vitro in the presence
or absence of the 26S proteasome inhibitor MG132 [15,wild-type, but do not play a major role in protein stability
once c-Abl has adopted the activated state (open confor- 16]. The c-AblSH3 protein was significantlymore stable
in the presence of MG132, with an average increase inmation) elicited by the P131L mutation. These findings
are in agreementwith previous reports showing that, while protein half-life of 3.4  0.9 hr over the control (Figure
3b). The stability of c-AblSH3 in cells was also increasedmutation of tyrosines 245 and 412 in c-Abl wild-type dra-
matically decreases c-Abl enzymatic activity in vitro, mu- significantly after inhibition of the 26S proteasome by
MG132. The half-life of c-Abl SH3 in the presence oftation of these tyrosines in c-Abl P131L only decreases
specific activity by less than 2-fold [14]. the solvent dimethyl sulphoxide (DMSO) was 8  3 hr,
compared to 29 12 hr in the presence of MG132 (Figure
3c). Thus, activated c-Abl SH3 is downregulated by the
26S proteasome inhibition induces accumulation 26S proteasome in vitro and in vivo.of tyrosine-phosphorylated c-Abl
A possible mechanism that may explain the differences
in stability between activated and nonactivated c-Abl pro- If tyrosine-phosphorylated c-Abl is regulated through the
proteasome, then inhibition of the proteasome shouldteins is an increased susceptibility of activated Abl pro-
teins to degradation through an ATP-dependent protein augment the levels of endogenous, tyrosine-phosphory-
lated c-Abl. To test this hypothesis, we used cells express-degradation pathway. To test this possibility, ATP was
substituted in the reaction with ATPS, a nonhydrolyz- ing activated v-Src, which produces high levels of acti-
vated c-Abl [6]. The 26S proteasome was inhibited withable ATP analog. The addition of ATPS increased the
stability of c-Abl P131L (Figure 3a) and c-Abl SH3 (data MG132 in the presence of cycloheximide to prevent the
synthesis of new protein. A faint band corresponding tonot shown) to levels that were similar to that of wild-
type c-Abl (Figure 3a). Thus, decreased stability of the tyrosine-phosphorylated c-Abl is detected in the absence
of proteasome inhibition, which clearly increased afteractivated forms of c-Abl occurs through an ATP-depen-
dent proteolytic pathway, such as that associated with the MG132 treatment (Figure 3d, upper panel). The levels
of total c-Abl also increased after MG132 treatment, asdegradation by the 26S proteasome.
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expected (Figure 3d, middle panel). In contrast, the levels A recent report showed that c-Abl can be dephosphory-
lated and inactivated by tyrosine-specific phosphatasesof Erk protein (Figure 3d, bottom panel) and v-Src (data
not shown) remained unchanged. Therefore, the differ- [21]. Our data suggest that tyrosine-phosphorylated c-Abl
can undergo another type of inactivation: an irreversibleences in c-Abl tyrosine phosphorylation are not due to
changes in the levels of v-Src. Significantly, we also de- downregulation by the 26S proteasome that would pre-
vent deregulation of cellular processes involving signalingtected tyrosine phosphorylation of endogenous c-Abl after
inhibition of the proteasome and after platelet-derived pathways downstream of activated c-Abl kinases.
growth factor (PDFG) and pervanadate treatment in
Supplementary materialNIH-3T3 fibroblasts (Figure 3e). Interestingly, the tyro-
Supplementary material including additional Materials and methods issine-phosphorylated c-Abl pool is clearly increased after
available at http://images.cellpress.com/supmat/supmatin.htm.
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